43 results match your criteria diabetes gestacional


Seventy eight children born small for gestational age without catch-up growth treated with growth hormone from the prepubertal stage until adult height age. An evaluation of puberty and changes in the metabolic profile.

Endocrinol Diabetes Nutr 2021 Jun 11. Epub 2021 Jun 11.

Pediatric Endocrinology Unit, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Research Institut, Paediatric Endocrinology, Vall d'Hebron University Hospital, Barcelona, Spain; Autonomous University of Barcelona, Barcelona, Spain.

A wide variation in height gain rate is observed in children small for gestational age (SGA) treated with growth hormone (GH). The aim of this study was to evaluate prepubertal and pubertal growth, height gain attained at adult age and to assess potential predictive factors in catch-up growth. Changes in metabolic profile were also analyzed. Read More

View Article and Full-Text PDF

General practitioners' knowledge about pregnancy complications associated with long-term cardiovascular risk.

Gac Med Mex 2021 ;157(1):47-51

Division of Endocrinology, Diabetes and Hypertension, Brigham & Women's Hospital, Harvard Medical School, Boston, United States.

Introduction: Cardiovascular disease (CVD) is the leading cause of mortality in women; preeclampsia (PE) and gestational diabetes mellitus (GDM) are associated with an increased risk of CVD.

Objective: To evaluate general practitioners (GP) knowledge about complicated pregnancies and their association with CVD.

Methods: An anonymous case-based electronic questionnaire designed to assess the level of understanding on the influence of a history of pregnancy complications on long-term cardiovascular risk and general knowledge about CVD risk was sent to GPs. Read More

View Article and Full-Text PDF
January 2021

Protocol for a randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes: Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional.

Trials 2021 Apr 7;22(1):256. Epub 2021 Apr 7.

Weight Control and Diabetes Research Center, The Miriam Hospital, Providence, USA.

Background: Gestational diabetes mellitus (GDM) is associated with several maternal complications in pregnancy, including preeclampsia, preterm labor, need for induction of labor, and cesarean delivery as well as increased long-term risks of type 2 diabetes, metabolic syndrome, and cardiovascular disease. Intrauterine exposure to GDM raises the risk for complications in offspring as well, including stillbirth, macrosomia, and birth trauma, and long-term risk of metabolic disease. One of the strongest risk factors for GDM is the occurrence of GDM in a prior pregnancy. Read More

View Article and Full-Text PDF

Uso de mioinositol más Bifidobacterium lactis y Lactobacillus rhamnosus para la prevención de diabetes mellitus gestacional en mujeres mexicanas.

Gac Med Mex 2020 ;156(Supl 3):S51-S57

Servicio de Ginecología y Obstetricia, Hospital Faro del Mayab, Mérida, Yuc. México.

Aim: To compare the incidence of gestational diabetes mellitus (GDM) in women with three or more risk factor to developing GDM supplemented with myo-inositol plus probiotics versus women care without supplementation.

Methods: Retrospective cohort study, group 1, women with supplementation (myo-inositol 2g plus Bifidobacterium lactis and Lactobacillus rhamnosus 5x108 UFC, twice per day, from 12-14 to 28 weeks of gestation; group 2, women with prenatal care without supplementation, matched by age and body mass index (BMI). The primary outcome was the incidence of GDM using the International Association of Diabetes and Pregnancy Study Groups criteria. Read More

View Article and Full-Text PDF
January 2020

Suplementos nutricionales para prevención de diabetes mellitus gestacional: lecciones aprendidas basadas en la evidencia.

Gac Med Mex 2020 ;156(Supl 3):S43-S50

Centro de Investigación Translacional en Ciencias de la Salud, Hospital General Dr. Manuel Gea González. Ciudad de México, México.

Introduction: Gestational diabetes mellitus (GDM) affects between 5 and 40% of pregnant women. Recently different interventions with nutritional supplements have been evaluated for prevention of GDM.

Aim: To perform a synthesis of the evidence on the efficacy of nutritional supplements (myo-inositol, probiotics, and vitamin D) in the prevention of GDM. Read More

View Article and Full-Text PDF
January 2020

Obesity, gestational weight gain, and birth weight in women with gestational diabetes: the LINDA-Brasil (2014-2017) and the EBDG (1991-1995) studies.

J Pediatr (Rio J) 2021 Mar-Apr;97(2):167-176. Epub 2020 Apr 10.

Universidade Federal do Rio Grande do Sul (UFRGS), Faculdade de Medicina, Departamento de Medicina Social, Programa de Pós-Graduação em Epidemiologia, Porto Alegre, RS, Brazil; Universidade Federal do Rio Grande do Sul (UFRGS), Faculdade de Medicina, Departamento de Nutrição, Programa de Pós-Graduação em Alimentação, Nutrição e Saúde, Porto Alegre, RS, Brazil. Electronic address:

Objective: This study aimed to evaluate gestational weight gain and birth weight in women with gestational diabetes mellitus of two Brazilian cohorts enrolled three decades apart.

Methods: The authors compared data of 2362 women from the Lifestyle INtervention for Diabetes Prevention After Pregnancy study (LINDA-Brasil, 2014-2017) to those of 359 women from the Estudo Brasileiro de Diabetes Gestacional study (EBDG, 1991-1995). Gestational weight gain was classified by the 2009 Institute of Medicine criteria; large and small for gestational age newborns, by the Intergrowth-21 chart. Read More

View Article and Full-Text PDF

Effects of probiotics on blood glucose, biomarkers of inflammation and oxidative stress in pregnant women with gestational diabetes mellitus: A meta-analysis of randomized controlled trials.

Med Clin (Barc) 2020 03 17;154(6):199-206. Epub 2019 Oct 17.

Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Background: The role of probiotics supplementation in gestational diabetes mellitus (GDM) remains controversial. We conducted this meta-analysis to investigate the effects of probiotics on fasting blood glucose (FBG), high-sensitivity C-reactive protein (hs-CRP), total glutathione (GSH), malonaldehyde (MDA) and nitric oxide (NO) levels in pregnant women with GDM.

Methods: We systematically searched the Cochrane Library, Embase and PubMed electronic databases up to November 2018. Read More

View Article and Full-Text PDF

Implication of gestational diabetes treatment on maternal weight gain and low neonatal weight: a large retrospective cohort study.

Nutr Hosp 2019 Dec;36(6):1261-1266

Hospital Universitario Ramón y Cajal.

Introduction: Objective: the treatment for gestational diabetes is based on diet, and this may modify maternal weight gain. The limited maternal weight gain is related to newborns with small weight for their gestational age (SGA), and many studies have found an increase of SGA in women with gestational diabetes (GD), but the reason for this is not clear. The objective of this study is to evaluate the effects of gestational diabetes treatment on maternal weight gain and neonatal weight. Read More

View Article and Full-Text PDF
December 2019

Detection, treatment and prevention programs for gestational diabetes mellitus: The St Carlos experience.

Endocrinol Diabetes Nutr (Engl Ed) 2020 May 11;67(5):342-350. Epub 2019 Sep 11.

Administrative Staff, Nurses.

Gestational diabetes mellitus (GDM) increases the risk of adverse events in pregnancy and jeopardizes long-term health of the mother and offspring. There is currently no consensus as to what screening strategies improve the efficiency of GDM diagnosis. Which criteria should be used? Is the one-step or two-step procedure better? There is no agreement as to what the best dietary approach in the treatment of GDM is. Read More

View Article and Full-Text PDF

Nutritional habits and levels of physical activity during pregnancy, birth and the postpartum period of women in Toledo (Spain): study protocol for a two-year prospective cohort study (the PrePaN study).

BMJ Open 2019 07 30;9(7):e029487. Epub 2019 Jul 30.

School of Education, Universidad de Castilla- La Mancha, Cuenca, Spain.

Introduction: Pregnant women who eat a balanced diet usually practice physical activity (PA) regularly; there are many studies on PA during pregnancy and the results for the mother and baby. However, the guideline for PA during pregnancy is very general and is not quantified. The primary objective of this study is to examine the nutritional habits and levels of PA of women during pregnancy and the postpartum period. Read More

View Article and Full-Text PDF

Alterations of carbohydrate metabolism during pregnancy. Effects on the mother and new born infant.

Med Clin (Barc) 2020 02 22;154(4):119-124. Epub 2019 Jun 22.

Área de Medicina Preventiva y Salud Pública, Departamento de Medicina Preventiva y Salud Pública, Ciencias de la Alimentación, Toxicología y Medicina Legal, Universidad de Valencia, Burjassot, Valencia, España; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, España.

Introduction: Gestational diabetes is the pathology that most frequently causes medical alterations in pregnancy. The objective of this study was to assess the relationship between the presence of alterations in the metabolism of carbohydrates during pregnancy and the risk of adverse obstetric outcomes in mother and foetus.

Patients And Method: An observational study was conducted on 799 women who had just given birth. Read More

View Article and Full-Text PDF
February 2020

Diagnosis, treatment, and management of gestational hypothyroidism. The TIROGEST study.

Endocrinol Diabetes Nutr (Engl Ed) 2020 Jan 17;67(1):36-42. Epub 2019 May 17.

Hospital Comarcal de Inca, Inca, Mallorca, Spain.

Introduction: There is no agreement on the procedures to be used for diagnosis and treatment of gestational thyroid dysfunction. Controversy still exists on the normal range of thyroid-stimulating hormone (TSH) levels and use of gestational hypothyroidism (GH) screening. The aim of this study was to assess diagnosis and treatment of thyroid dysfunction during pregnancy in a group of Spanish hospitals. Read More

View Article and Full-Text PDF
January 2020

Predictors of postpartum diabetes mellitus in patients with gestational diabetes.

Endocrinol Diabetes Nutr (Engl Ed) 2019 Feb 15;66(2):83-89. Epub 2018 Nov 15.

Servicio de Endocrinología y Nutrición, Hospital Universitario Gregorio Marañón, Madrid, España.

Introduction: Gestational diabetes (GD) is related to development of diabetes mellitus (DM) after delivery. The predictive factors in this association are not yet well defined. Objetive: to study the predictive factors of dysglucosis in the postpartum period in a sample of patients with GD. Read More

View Article and Full-Text PDF
February 2019

Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature.

Case Rep Crit Care 2018 1;2018:1747850. Epub 2018 Oct 1.

Hospital Británico de Buenos Aires, Intensive Care Services, Argentina.

Diabetic ketoacidosis (DKA) is an acute complication of diabetes mellitus, both type I and type II, as well as other types with diabetes such gestacional diabetes mellitus. It is characterized by blood glucose levels greater than 250 mg/dL and metabolic acidosis (pH < 7.3 and serum bicarbonate < 15 mEq/dL) with an increased anion gap and the presence of ketone bodies in the blood or urine. Read More

View Article and Full-Text PDF
October 2018

Are cord blood visfatin concentrations different depending on birth weight category?

Endocrinol Diabetes Nutr (Engl Ed) 2019 Jan 16;66(1):35-40. Epub 2018 Oct 16.

Department of Pediatrics, University Hospital "Dr. José Eleuterio González" Universidad Autónoma de Nuevo León, Monterrey, Mexico. Electronic address:

Background And Objective: Increased visceral adipose tissue mass is strongly associated to metabolic disorders. Visfatin is a visceral fat adipocytokine. There is epidemiological evidence of a link between a suboptimal gestational environment and a greater propensity to develop metabolic disease in adult life. Read More

View Article and Full-Text PDF
January 2019

Gestational diabetes mellitus in a multiethnic population in Spain: Incidence and factors associated to impaired glucose tolerance one year after delivery.

Endocrinol Diabetes Nutr (Engl Ed) 2019 Apr 9;66(4):240-246. Epub 2018 Oct 9.

Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, España; Servicio de Endocrinología y Nutrición, Hospital del Mar, Barcelona, España.

Background And Aim: Women with history of gestational diabetes mellitus (GDM) are at increased risk for diabetes. Ethnicity may modify such risk, but no studies have been conducted in our environment. The aim of this study was to assess the incidence of type 2 diabetes mellitus and prediabetes one year after delivery in women with GDM and in a multiethnic background and to identify the associated factors. Read More

View Article and Full-Text PDF

Fasting glucose in the first trimester: An initial approach to diagnosis of gestational diabetes.

Endocrinol Diabetes Nutr (Engl Ed) 2019 Jan 3;66(1):11-18. Epub 2018 Sep 3.

Servicio de Urgencias, Hospital de Fuenlabrada, Fuenlabrada, Madrid, España.

Objectives: To establish whether fasting glucose levels in the first trimester (FGFT)of pregnancy ≥ 92 mg/dL (5.1 mmol/L) (FGFT) anticipate the occurrence of maternal-fetal complications of gestational diabetes mellitus. To assess whether FGFT can replace diagnosis of GDM using the classical two-step oral glucose tolerance test (OGTT). Read More

View Article and Full-Text PDF
January 2019

[Antecedentes maternos prenatales y riesgo de complicaciones neonatales en productos de término de bajo peso para edad gestacional].

Bol Med Hosp Infant Mex 2018 ;75(4):237-243

Hospital Español de México. Ciudad de México, México.

Introducción: El bajo peso neonatal (< 2.5 kg o < percentil 10) se atribuye a causas constitucionales (pequeño para la edad gestacional [PEG]) o a la restricción en el crecimiento intrauterino (RCIU), con riesgos posnatales diferentes. En ausencia de una valoración fetal-placentaria prenatal adecuada, resulta difícil establecerlo. Read More

View Article and Full-Text PDF

Predictors of excess birth weight in Brazil: a systematic review.

J Pediatr (Rio J) 2019 Mar - Apr;95(2):128-154. Epub 2018 May 19.

Universidade da Região de Joinville (UNIVILLE), Programa de Pós-Graduação em Saúde e Meio Ambiente, Joinville, SC, Brazil. Electronic address:

Objective: To describe the main predictors for excess birth weight in Brazilian children.

Data Sources: Systematic review carried out in the bibliographic databases: PubMed/MEDLINE, Cochrane, Scopus, Web of Science, and LILACS. The research in the gray literature was performed using the Google Scholar database. Read More

View Article and Full-Text PDF
October 2019

Gestational diabetes mellitus: glycemic control during pregnancy and neonatal outcomes of twin and singleton pregnancies.

Endocrinol Diabetes Nutr (Engl Ed) 2018 Jun - Jul;65(6):319-327. Epub 2018 Apr 21.

Unidad de Diabetes, Departamento de Endocrinología y Nutrición, Hospital Universitario La Paz, Madrid, España.

Objective: To assess the impact of glycemic control in gestational on neonatal weight and metabolic complications of twin and singleton pregnancies.

Methods: An observational, retrospective study to monitor 120 twin and 240 singleton pregnancies in women with GDM. Maternal glycemic parameters during pregnancy (oral glucose tolerance test results, treatment, insulinization rate, mean HbA1c in the third trimester), and neonatal complications and weight were recorded. Read More

View Article and Full-Text PDF

Usefulness of blood pressure monitoring in patients with gestational diabetes mellitus.

Endocrinol Diabetes Nutr (Engl Ed) 2018 Aug - Sep;65(7):394-401. Epub 2018 Apr 19.

Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta del Mar, Facultad de Medicina, Universidad de Cádiz, Cádiz, España. Electronic address:

Background And Objective: Gestational diabetes mellitus (GDM) is associated to an increased risk of pregnancy-induced hypertension (PIH). Ambulatory blood pressure monitoring (ABPM) has been used to detect PIH and preeclampsia, but few data are currently available on its use in women with GDM. The aim of this study was to achieve early identification in women with GDM of BP profiles (detected by ABPM) that could define a population at greater risk of developing PIH and preeclampsia. Read More

View Article and Full-Text PDF

Comparison of Citrate Buffer with Sodium Fluoride as Additives in Determining Glycemia.

Clin Lab 2017 Nov;63(11):1939-1944

Background: The objectives of this study are to compare the effect of sodium fluoride and citrate on the stability of glucose in samples maintained at room temperature up to three hours, and to assess the clinical impact in the O'Sullivan test results after changing the additives in the collecting tubes.

Methods: The selected population was pregnant women between the 24th and 28th week of gestation, who were at the health center to undergo the O'Sullivan test as part of the screening program for GDM (gestacional diabetes mellitus). Two blood samples were extracted from each patient: one using a tube with citrate and sodium fluoride buffer (tubes Vacuette Glucomedics citrate, 2 mL, Ref 454347) (tube C) and another containing just sodium fluoride (BD Vacationer tubes FX fluoride, 2 mL, Ref 368920) (tube F). Read More

View Article and Full-Text PDF
November 2017

Unfavorable cytokine and adhesion molecule profiles during and after pregnancy, in women with gestational diabetes mellitus.

Endocrinol Diabetes Nutr 2017 Jan 19;64(1):18-25. Epub 2017 Jan 19.

Department of Endocrinology, Puerta del Mar Hospital, Cádiz, Spain. Electronic address:

Background: Gestational diabetes mellitus is a significant risk factor for metabolic syndrome and cardiovascular disease.

Aims: To assess the relationships between components of the metabolic syndrome and cytokine and adhesion molecule levels in women with GDM during pregnancy and after delivery.

Patients And Methods: A prospective case-control study on a sample of 126 pregnant women (63 with and 63 without gestational diabetes mellitus). Read More

View Article and Full-Text PDF
January 2017

[Suitability of screening for diabetes mellitus in women with a history of gestational diabetes].

Rev Calid Asist 2017 May - Jun;32(3):135-140. Epub 2017 Feb 4.

Medicina de Familia, Centro de Saúde Vilardevós, Orense, España.

Objective: To assess long-term suitability of screening for type 2 diabetes mellitus in women with a previous diagnosis of gestational diabetes in Primary Care. The secondary objectives were to determine if there were clinical factors that modified the usefulness of the screening.

Material And Methods: An observational cohort type study was performed, which included all patients with the diagnosis of gestational diabetes during the years 2000 to 2009 (n=470) in the University Hospital Complex of Ourense. Read More

View Article and Full-Text PDF

Sobrepeso y obesidad maternos como factores de riesgo independientes para que el parto finalice en cesárea.

Nutr Hosp 2016 Nov 29;33(6):1324-1329. Epub 2016 Nov 29.

Unidad de Obstetricia y Ginecología. Hospital Universitario de Puerto Real. Servicio Andaluz de Salud.

Introducción: el sobrepeso y la obesidad se asocian a una mayor probabilidad de que el parto finalice en cesárea. Dado que dicho incremento del riesgo podría estar sesgado por variables de confusión como la diabetes o la hipertensión, en el presente trabajo pretendemos determinar si este riesgo persiste tras ser ajustado por numerosas variables de control.Objetivo: determinar si el sobrepeso y/o la obesidad son factores de riesgo independientes para que el parto finalice en cesárea. Read More

View Article and Full-Text PDF
November 2016

[Maternal metabolic diseases related to pre-pregnancy overweight and obesity in mexican women with high risk pregnancy].

Cir Cir 2017 Jul - Aug;85(4):292-298. Epub 2016 Dec 9.

Unidad de Investigación Social, Epidemiológica y en Servicios de Salud, Delegación Estatal Jalisco, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.

Introduction: Pre-pregnancy obesity has been proposed as a risk factor related to gestational diabetes and hypertensive disorders during pregnancy.

Objectives: Identify pregnancy related diseases associated with pre-pregnancy obesity as a risk factor ina high risk preganancy patient population.

Methods: 600 patients whose pre-pregnancy obesity had been assessed as a high risk factor were included in the study. Read More

View Article and Full-Text PDF

Neonatal outcomes according to different therapies for gestational diabetes mellitus.

J Pediatr (Rio J) 2017 Jan - Feb;93(1):87-93. Epub 2016 Jun 28.

Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.

Objectives: To compare different neonatal outcomes according to the different types of treatments used in the management of gestational diabetes mellitus.

Methods: This was a retrospective cohort study. The study population comprised pregnant women with gestational diabetes treated at a public maternity hospital from July 2010 to August 2014. Read More

View Article and Full-Text PDF

Perinatal outcome of macrosomic infants born to diabetic versus non-diabetic mothers.

Endocrinol Nutr 2016 Oct 4;63(8):409-13. Epub 2016 Jun 4.

Unidad de Neonatología y Unidad de Cuidados Intensivos Neonatales, Hospital Universitario Santa Lucía, Complejo Hospitalario Universitario de Cartagena, Cartagena, Murcia, España.

Objective: To assess the incidence and perinatal complications of macrosomic infants born to diabetic and non-diabetic mothers.

Patients And Methods: A six-year retrospective study of newborns at our hospital. A total of 996 macrosomic newborns were found. Read More

View Article and Full-Text PDF
October 2016

[Placental atherosclerosis and markers of endothelial dysfunction in infants born to mothers with gestational diabetes].

Med Clin (Barc) 2016 Aug 27;147(3):95-100. Epub 2016 May 27.

Departamento de Patología, Hospital General Regional 1, Instituto Mexicano del Seguro Social, Obregón, Sonora, México.

Background And Objective: The pathophysiology of gestational diabetes itself causes hyperstimulation of adipose tissue and of the placenta cells increasing the production of inflammatory cytokines, which cause changes in the tissues exposed such as the placenta and foetus. Therefore, the objective of this study was to compare metabolic markers and endothelial dysfunction in umbilical cord blood, as well as to determine the presence of atherosclerosis in the placentas of newborn infants of patients with gestational diabetes and in patients with normally progressing pregnancies.

Patients And Method: An analytical cross-sectional study was carried out in 84 patients, obtaining data such as age, smoking and weight gain in pregnancy; the gestational age of the newborns was determined by Capurro, and their weight and destination subsequent to birth, the placentas were also collected in order to look for atherosclerosis through histological studies and glucose, insulin, VLDL-C, HDL-C, triglycerides, cholesterol, fibrinogen, PCR and markers of endothelial dysfunction (adiponectin, VCAM-1, ICAM-1 and IL-6) were determined in blood samples obtained from the umbilical cord. Read More

View Article and Full-Text PDF